Search

everythinglearnresearchcommunity

for

Search:↓

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.